Naloxone
9
1
1
6
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Low Risk
Score: 27/100
0.0%
0 terminated out of 9 trials
100.0%
+13.5% vs benchmark
22%
2 trials in Phase 3/4
50%
3 of 6 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 6 completed trials
Clinical Trials (9)
Vending Machine Naloxone Distribution for Your Community (VENDY)
Naloxone for Opioid Associated Out of Hospital Cardiac Arrest
Nalox-Comm: Naloxone Communication Training for Pharmacists
Increasing Naloxone Access for Persons Who Use Opioids
Observational Study of Misuse of High Dose Buprenorphine (Subutex® or Generic) in Opiate-Addicted Patients in France (Study P05186AM1)(COMPLETED)
Treatment of Gambling Disorder With Fast Acting Opiate Antagonist, Naloxone Nasal Spray
A Usability Assessment of Naloxone Administration by Untrained Community Members
Effects of Intranasal Naloxone on Gambling Urges and Craving in Gambling Disorder
Effect of High Dose Naloxone on Secondary Hyperalgesia